Identify disease targets and perturbagens that modulate XDP-disease phenotypes with robotic microscopy, deep learning and OMICS in human in vitro XDP cell models
History
2022
Leslie Thompson, PhD, University of California at Irvine
Steven Finkbeiner, MD, PhD, UCSF/Gladstone Institutes
